论文信息 - Establishment of a conversion factor for the Cepheid GeneXpert BCR-ABL assay. - 字舞流文

Establishment of a conversion factor for the Cepheid GeneXpert BCR-ABL assay.

D. Talaulikar | Michelle McNiven | D Talaulikar | M. McNiven

[1] A. Beckett,et al. AKUFO AND IBARAPA. , 1965, Lancet.

[2] Martin C. Müller,et al. An international study to standardize the detection and quantitation of BCR-ABL transcripts from stabilized peripheral blood preparations by quantitative RT-PCR. , 2007, Haematologica.

[3] Martin C. Müller,et al. Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials. , 2008, Blood.

[4] J. Goldman,et al. Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia , 2006, Leukemia.

[5] Simona Soverini,et al. Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. , 2006, Blood.

[6] D. Ross,et al. Current and emerging tests for the laboratory monitoring of chronic myeloid leukaemia and related disorders. , 2008, Pathology.

[7] Paul Metcalfe,et al. Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA. , 2010, Blood.

[8] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.